COOPER COMPANIES, INC.
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures adjusted for later stock splits (split ratios inferred from EPS restated in later SEC filings).
CAPITALIZATION 10/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 2,552 | 23.7 |
| Stockholders' equity | 8,239 | 76.3 |
| Total capitalization | 10,791 | 100.0 |
190,155,294 shares outstanding at 3 September 2026 (cover page of the 10-Q filed 9 September 2026).
LONG-TERM DEBT 10/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 2,505 |
| Long-term debt, noncurrent | 2,456 |
| Current maturities | 48 |
| Short-term borrowings / commercial paper | 47 |
CAPITAL STOCK 10/31/25
| Common shares authorized | 480,000,000 |
| Common shares issued | 217,600,000 |
| Treasury shares | 21,700,000 |
| Par or stated value per share ($) | 0.1 |
| Preferred stock ($ millions) | 0 |
| Outstanding at 9/3/26 | 190,155,294 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | – | – |
| 2024 | – | – |
| 2023 | 0.01 | 0.5 |
| 2022 | 0.01 | 0.4 |
| 2021 | 0.01 | 0.1 |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware.
BUSINESS: Classified by the SEC under Standard Industrial Classification 3851, Ophthalmic Goods. Large accelerated filer. Principal executive office: 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA 94583. Fiscal year ends October 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 10/31/25 | 10/31/24 | 10/31/23 |
|---|---|---|---|
| Revenues | 4,092 | 3,895 | 3,593 |
| Cost of revenues | 1,410 | 1,300 | 1,235 |
| Gross profit | 2,682 | 2,596 | 2,358 |
| Research and development | 172 | 155 | 137 |
| Selling, general and administrative | 1,628 | 1,534 | 1,501 |
| Depreciation and amortization | 377 | 375 | 368 |
| Operating income | 683 | 706 | 533 |
| Interest expense | 100 | 114 | 105 |
| Income before income taxes | 566 | 582 | 413 |
| Income taxes | 192 | 190 | 119 |
| Net income | 375 | 392 | 294 |
| Earned per share, diluted ($) | 1.87 | 1.96 | 1.48 |
| Dividends per share ($) | – | – | 0.01 |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 10/31/25 | 10/31/24 |
|---|---|---|
| Cash and equivalents | 111 | 108 |
| Receivables, net | 829 | 717 |
| Inventories | 846 | 803 |
| Total current assets | 2,106 | 1,952 |
| Property, plant and equipment, net | 2,080 | 1,860 |
| Goodwill | 3,853 | 3,838 |
| Total assets | 12,395 | 12,315 |
| Total current liabilities | 1,113 | 1,023 |
| Long-term debt | 2,456 | 2,548 |
| Total liabilities | 4,156 | 4,232 |
| Stockholders' equity | 8,239 | 8,083 |
| Total liabilities and equity | 12,395 | 12,315 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/31/25 | 4,092 | 683 | 375 | 9.2 | 1.87 | – | 796 | 362 | 434 | 12,395 | 4,156 | 2,552 | 8,239 | 4.6 | 0.31 |
| 10/31/24 | 3,895 | 706 | 392 | 10.1 | 1.96 | – | 709 | 421 | 288 | 12,315 | 4,232 | 2,616 | 8,083 | 4.9 | 0.32 |
| 10/31/23 | 3,593 | 533 | 294 | 8.2 | 1.48 | 0.01 | 608 | 392 | 215 | 11,659 | 4,108 | 2,614 | 7,551 | 3.9 | 0.35 |
| 10/31/22 | 3,308 | 508 | 386 | 11.7 | 1.94 | 0.01 | 692 | 242 | 450 | 11,492 | 4,318 | 3,159 | 7,174 | 5.4 | 0.44 |
| 10/31/21 | 2,922 | 506 | 2,945 | 100.8 | 14.79 | 0.01 | 739 | 214 | 524 | 9,606 | 2,664 | 1,481 | 6,942 | 42.4 | 0.21 |
| 10/31/20 | 2,431 | 312 | 238 | 9.8 | 1.20 | 0.01 | 487 | 310 | 176 | 6,738 | 2,913 | 1,793 | 3,825 | 6.2 | 0.47 |
| 10/31/19 | 2,653 | 547 | 467 | 17.6 | 2.33 | 0.01 | 713 | 292 | 421 | 6,274 | 2,646 | 1,826 | 3,628 | 12.9 | 0.50 |
| 10/31/18 | 2,533 | 403 | 140 | 5.5 | 0.70 | 0.01 | 669 | 194 | 475 | 6,113 | 2,805 | 2,060 | 3,308 | 4.2 | 0.62 |
| 10/31/17 | 2,139 | 429 | 373 | 17.4 | 1.88 | 0.01 | 594 | 127 | 466 | 4,859 | 1,683 | 1,196 | 3,176 | 11.7 | 0.38 |
| 10/31/16 | 1,967 | 324 | 274 | 13.9 | 1.40 | 0.01 | 510 | 153 | 357 | 4,479 | 1,783 | 1,544 | 2,696 | 10.2 | 0.57 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
COOPER COMPANIES, INC.
CIK 711404 · EIN 94-2657368
PRINCIPAL OFFICE:
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA 94583
Tel.: 9254603600
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
3851 · Ophthalmic Goods
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 10/31/25, filed 5 December 2025
FORMER NAMES:
COOPER COMPANIES INC
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 12/5/25) · 10-K FY2024 (filed 12/6/24) · 10-K FY2023 (filed 12/8/23) · 10-K FY2022 (filed 12/9/22) · 10-K FY2021 (filed 12/10/21) · 10-K FY2020 (filed 12/11/20) · 10-K FY2019 (filed 12/20/19) · 10-K FY2018 (filed 12/21/18). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.